Interviews

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the role of the pharmacist in acute coronary syndrome management with platelet aggregation inhibitors.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how platelet aggregation inhibitors fit into the acute coronary syndrome management picture.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how closer integration of pharmacists into care teams improves outcomes for patients taking new oral anticoagulants.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how specialty pharmacies can meet the reporting requirements required by manufacturers and payers.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can help patients manage increasing copay costs.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses what documentation and communication a pharmacist could provide in emergency situations.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses what may be in a crash cart besides medication.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses the typical medications found in a crash cart.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses some ways pharmacists have helped in cardiopulmonary resuscitation efforts.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the benefits and risks of off-label use of new oral anticoagulants.

Teresa Rubio, PharmD, of the FDA Office on Health and Constituent Affairs, describes the process by which pharmacists can file reports with MedWatch.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the trend of larger entities absorbing independent specialty pharmacies.

Teresa Rubio, PharmD of the FDA Office on Health and Constituents Affairs describes the types of adverse drug events that pharmacists should report to MedWatch.

Natasha Nicol, PharmD, FASHP, director of Global Patient Safety Affairs at Cardinal Health, talks about how a pharmacist can be proactive in reducing the chance of errors.

Natasha Nicol, PharmD, FASHP, director of Global Patient Safety Affairs at Cardinal Health, provides prevention strategies to reduce medication errors.

Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses medication use risk outside the pharmacy.

James Hoffman, PharmD, MS, FASHP, describes negative trends affecting the pharmacy workforce.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient's renal function affects appropriate dosing of new oral anticoagulants.

James Hoffman, PharmD, MS, FASHP, explains how pharmacy practice settings may change going forward.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses the role of the pharmacist in optimizing care for heart failure with reduced ejection fracture patients.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, outlines how pharmacists can use their knowledge of key trends to patient care improvement efforts.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses how the approval of Entresto changed the heart failure care landscape.

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about some ways a pharmacy can differentiate itself from its competition.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, talks about what his experience has been like as an adviser for the South Carolina College of Pharmacy student business plan team.